METASTATIC PANCREATIC CANCER

Clinical trials for METASTATIC PANCREATIC CANCER explained in plain language.

Never miss a new study

Get alerted when new METASTATIC PANCREATIC CANCER trials appear

Sign up with your email to follow new studies for METASTATIC PANCREATIC CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 17 Not yet recruiting 1 Not yet finished but already full! 11 Completed 4 Terminated 5

New targeted drug takes on hard-to-treat pancreatic cancer

Disease control Not yet recruiting

This study tests a new drug, GFH375, against standard chemotherapy in 320 people with advanced pancreatic cancer that has a specific genetic change (KRAS G12D). Participants must have already tried at least one prior treatment. The goal is to see if GFH375 helps people live longe…

Matched conditions: METASTATIC PANCREATIC CANCER

Phase: PHASE3 • Sponsor: Genfleet Therapeutics (Shanghai) Inc. • Aim: Disease control

Last updated May 17, 2026 01:05 UTC

METASTATIC PANCREATIC CANCER

Get alerted when new METASTATIC PANCREATIC CANCER trials appear

New targeted drug takes on hard-to-treat pancreatic cancer